Eurazeo Past Earnings Performance

Past criteria checks 0/6

Eurazeo has been growing earnings at an average annual rate of 39.2%, while the Diversified Financial industry saw earnings growing at 0.6% annually. Revenues have been declining at an average rate of 16.8% per year.

Key information

39.2%

Earnings growth rate

39.5%

EPS growth rate

Diversified Financial Industry Growth	9.1%
Revenue growth rate	-16.8%
Return on equity	-0.9%
Net Margin	-22.9%
Last Earnings Update	30 Jun 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Eurazeo makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

DB:EUQ Revenue, expenses and earnings (EUR Millions)
Date	Revenue	Earnings	G+A Expenses
30 Jun 24	338	-77	183
31 Mar 24	371	873	182
31 Dec 23	405	1,824	182
30 Sep 23	1,994	2,156	464
30 Jun 23	3,583	2,488	746
31 Mar 23	4,615	1,542	995
31 Dec 22	5,646	595	1,245
30 Sep 22	5,894	801	1,489
30 Jun 22	6,142	1,007	1,734
31 Mar 22	6,450	1,294	1,952
31 Dec 21	6,759	1,580	2,170
30 Sep 21	6,051	1,142	2,070
30 Jun 21	5,343	703	1,971
31 Mar 21	4,881	271	1,912
31 Dec 20	4,419	-161	1,853
30 Sep 20	4,385	-303	1,899
30 Jun 20	4,352	-444	1,946
31 Mar 20	4,748	-165	1,980
31 Dec 19	5,143	114	2,014
30 Sep 19	5,125	193	1,976
30 Jun 19	5,106	271	1,939
31 Mar 19	5,013	280	1,899
31 Dec 18	4,920	289	1,859
30 Sep 18	4,795	394	1,785
30 Jun 18	4,671	499	1,712
31 Mar 18	4,344	490	1,605
31 Dec 17	4,017	481	1,498
30 Sep 17	4,026	552	1,421
30 Jun 17	4,036	624	1,344
31 Mar 17	3,522	575	1,161
31 Dec 16	3,009	525	978
30 Sep 16	3,097	302	1,299
30 Jun 16	1,389	79	583
31 Mar 16	2,588	678	811
31 Dec 15	3,788	1,277	1,038
30 Sep 15	3,721	1,276	944
30 Jun 15	5,452	1,276	1,888
31 Mar 15	4,785	593	2,001
31 Dec 14	4,118	-89	2,114
30 Sep 14	4,255	25	2,077
30 Jun 14	4,392	139	2,041
31 Mar 14	4,817	350	2,060
31 Dec 13	5,243	561	2,080

Quality Earnings: EUQ is currently unprofitable.

Growing Profit Margin: EUQ is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: EUQ is unprofitable, but has reduced losses over the past 5 years at a rate of 39.2% per year.

Accelerating Growth: Unable to compare EUQ's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: EUQ is unprofitable, making it difficult to compare its past year earnings growth to the Diversified Financial industry (-11%).

Return on Equity

High ROE: EUQ has a negative Return on Equity (-0.88%), as it is currently unprofitable.

Eurazeo Past Earnings Performance

Past criteria checks 0/6

Key information

Recent past performance updates

First half 2024 earnings released: €1.43 loss per share (vs €25.36 profit in 1H 2023)

Full year 2023 earnings released: EPS: €25.94 (vs €8.33 in FY 2022)

Eurazeo SE to Report Fiscal Year 2023 Results on Mar 07, 2024

Eurazeo SE to Report First Half, 2023 Results on Jul 27, 2023

Full year 2022 earnings released: EPS: €8.33 (vs €22.17 in FY 2021)

Eurazeo SE to Report First Half, 2022 Results on Jul 27, 2022

Recent updates

Eurazeo SE (ENXTPA:RF) and management of Eres acquired an unknown majority stake in Eres Gestion from IK VIII, a fund managed by IK Partners.

First half 2024 earnings released: €1.43 loss per share (vs €25.36 profit in 1H 2023)

Eurazeo SE (ENXTPA:RF) and Marlin Equity Partners, LLC agreed to acquire an unknown majority stake in Rydoo N.V. from Marlin Equity Partners, LLC.

Bridgepoint Europe VII fund managed by Bridgepoint Group plc (LSE:BPT) signed an agreement to acquire unknown majority stake in LumApps SAS from a group of shareholders for $650 million.

Cathia Lawson-Hall Joins the Board of Eurazeo SE as Non-Executive Director

Eurazeo SE, Annual General Meeting, May 07, 2025

Upcoming dividend of €2.42 per share

Eurazeo SE (ENXTPA:RF) and management of Eres signed an agreement to acquire an unknown majority stake in Eres Gestion from IK VIII, a fund managed by IK Partners on April 22, 2024.

Carl Zeiss Meditec AG (XTRA:AFX) completed the acquisition of Dutch Ophthalmic Research Center (International) B.V. from Eurazeo China Acceleration Fund and Eurazeo Capital IV funds managed by Eurazeo SE (ENXTPA:RF).

Carl Zeiss Meditec AG (XTRA:AFX) completed the acquisition of Dutch Ophthalmic Research Center (International) B.V. from Eurazeo China Acceleration Fund and Eurazeo Capital IV funds managed by Eurazeo SE (ENXTPA:RF).

New minor risk - Earnings quality

Full year 2023 earnings released: EPS: €25.94 (vs €8.33 in FY 2022)

Advanced Medical Solutions Group plc (AIM:AMS) entered into an agreement to acquire Péters Surgical SASU from Eurazeo SE (ENXTPA:RF) and others for €140 million.

Advanced Medical Solutions Group plc (AIM:AMS) entered into an agreement to acquire Péters Surgical SASU from Eurazeo SE (ENXTPA:RF) and others for €140 million.

Eurazeo SE (ENXTPA:RF) announces an Equity Buyback for €200 million worth of its shares.

Eurazeo SE, Annual General Meeting, May 07, 2024

Eurazeo SE (ENXTPA:RF) acquired 34% stake in BMS Group Limited from Bms Investment Holdings Limited.

Eurazeo SE to Report Fiscal Year 2023 Results on Mar 07, 2024

New major risk - Revenue and earnings growth

Eurazeo SE to Report First Half, 2023 Results on Jul 27, 2023

Upcoming dividend of €2.20 per share at 3.3% yield

Full year 2022 earnings released: EPS: €8.33 (vs €22.17 in FY 2021)

Eurazeo SE (ENXTPA:RF) alongside NeoXam's founder Serge Delpla and its management team led by Florent Fabre intered into an agreement to acquire NeoXam from Bpifrance Investissement SAS and Cathay Capital Private Equity SAS.

An investor group led by North Castle Partners, LLC has reached an agreement to acquire an unknown majority stake in Nest New York from Eurazeo SE (ENXTPA:RF).

carsales.com Ltd (ASX:CAR) completed the acquisition of remaining 51% stake in Trader Interactive, LLC from Eurazeo SE (ENXTPA:RF).

Macquarie Group Limited (ASX:MQG) in a consortium with British Columbia Investment Management Corporation and MEAG MUNICH ERGO Asset Management GmbH acquired Reden Solar for an enterprise value of €2.5 billion.

Eurazeo SE (ENXTPA:RF) alongside the WiiSmile's management team entered into agreement to acquire majority stake in WiiSmile SA.

Eurazeo SE to Report First Half, 2022 Results on Jul 27, 2022

Eurazeo SE (ENXTPA:RF) announces an Equity Buyback for €100 million worth of its shares.

Upcoming dividend of €3.00 per share

Eurazeo SE, Annual General Meeting, Apr 28, 2022

Investor sentiment improved over the past week

Eurazeo European Real Estate II, managed by Eurazeo SE (ENXTPA:RF) acquired Six mixed-use commercial properties from Gewerbesiedlungs-Gesellschaft Mit Beschränkter Haftung.

Eurazeo SE (ENXTPA:RF) and existing management team of Cranial Technologies, Inc. signed a definitive agreement to acquire Cranial Technologies, Inc. from BPOC and existing management team.

Eurazeo SE (ENXTPA:RF) agreed to acquire Five Ayre brand hotels from El Corte Inglés, S.A. and Palladium Hotel Group.

Eurazeo SE (ENXTPA:RF) acquire 80% stake in Ikaros Solar NV from its founders and FCPR Capenergie 2, fund managed by Omnes Capital S.A.S.

Eurazeo SE (ENXTPA:RF), Cherng Family Trust and Cohesive Capital Management, L.P. acquired a controlling stake in Beekman 1802 LLC for $92 million.

Safran Enters into Exclusive Discussions to Acquire Orolia

Safran Enters Exclusive Talks to Buy Navigation Technology Company

Eurazeo SE (ENXTPA:RF) along with Arax Properties Ltd entered into an agreement to acquire Trinity Trading Estate in Sittingbourne from St. James's Place plc (LSE:STJ).

carsales.com Ltd (ASX:CAR) completed the acquisition of a 49% stake in Trader Interactive, LLC from Eurazeo SE (ENXTPA:RF).

Eurazeo in Talks over Sale of Its Stake in Seqens

Montagu Private Equity LLP agreed to acquire unknown majority stake in In'Tech Medical SAS from Eurazeo SE (ENXTPA:RF).

Visa Inc. (NYSE:V) signed a definitive agreement to acquire Tink AB from SEB Venture Capital, PostePay SpA and others for €1.7 billion.

Eurazeo and Infravia Reportedly to Launch an Auction for Reden

Eurazeo SE (ENXTPA:RF), Theodore-Michel Vrangos and Laurent Charvériat entered into an agreement to acquire 49% stake in I-Tracing SAS from Keensight Capital for €165 million.

Upcoming dividend of €1.50 per share

Full year 2020 earnings released: €2.26 loss per share (vs €1.59 profit in FY 2019)

Eurazeo SE Announces Its Intention to Resume Distribution

Eurazeo SE to Report Fiscal Year 2020 Results on Mar 11, 2021

New 90-day high: €62.80

IK Investment Partners and Luxempart S.A. (BDL:LXMPR) agreed to acquire 20% stake in iM Global Partner from Eurazeo SE (ENXTPA:RF) for €70 million.

AppLovin Corporation entered into a definitive agreement to acquire adjust GmbH.

New 90-day high: €59.80

New 90-day high: €56.85

Eurazeo Capital managed by Eurazeo SE (ENXTPA:RF), IK Investment Partners Fund IX managed by IK Investment Partners and the management team completed the acquisition of an unknown majority stake in QUESTEL SAS from IK VIII, a fund of IK Investment Partners and Raise Investissement, SAS.

New 90-day high: €55.90

Croda International Plc (LSE:CRDA) completed the acquisition of Iberchem S.A. from Eurazeo Capital managed by Eurazeo SE (ENXTPA:RF) and others.

Croda International Plc (LSE:CRDA) agreed to acquire Iberchem S.A. from Eurazeo Capital managed by Eurazeo SE (ENXTPA:RF) and others for €820 million.

New 90-day high: €49.82

New 90-day low: €42.94

Hippocrates Holding Draws Up Shortlist of Four for Italy Pharmacy Network

Eurazeo Seeks to Buy Questel

Eurazeo Appoints Christophe Bavière as Head of Investment Partners

Volkswagen AG has entered into an agreement to sell Europcar International SA to Eurazeo SA for €3.32 billion.

Eurazeo Appoints Sophie Flak to Its Executive Committee

Eurazeo Reportedly in Negotiations to Take Majority Stake in EasyVista

Eurazeo SE (ENXTPA:RF) entered into an agreement to acquire of remaining 20% stake in Idinvest Partners SA from Christophe Bavière, Benoist Grossmann and their partners.

Eurazeo SE (ENXTPA:RF) completed the acquisition of 25% stake in MCH.